TABLE 2

Mean plasma and VLDL1 and VLDL2 lipids, apoB48 and B100 concentrations, FCRs, and production rates during the kinetic study in three experimental conditions

VariableINSSALINS + IH
Plasma FFA (mmol/l)0.12 ± 0.01*0.25 ± 0.050.29 ± 0.03
Plasma TG (mmol/l)1.03 ± 0.16*1.46 ± 0.101.91 ± 0.23
VLDL1 TG (mmol/l)0.21 ± 0.07*0.40 ± 0.030.50 ± 0.09
VLDL1 cholesterol (mmol/l)0.05 ± 0.02*0.10 ± 0.010.12 ± 0.03
VLDL1 apoB48
    Concentration (mg/l)0.90 ± 0.27*1.83 ± 0.191.63 ± 0.15
    FCR (pools/day)17.6 ± 5.612.3 ± 2.410.3 ± 1.1
    Production rate (mg · kg−1 · day−1)0.44 ± 0.14*0.93 ± 0.090.73 ± 0.06
VLDL1 apoB100
    Concentration (mg/dl)0.70 ± 0.16*1.76 ± 0.421.97 ± 0.51
    FCR (pools/day)11.8 ± 3.011.7 ± 0.98.2 ± 1.4
    Production rate (mg · kg−1 · day−1)3.40 ± 0.93*8.98 ± 2.056.09 ± 1.08
VLDL2 TG (mmol/l)0.19 ± 0.06*0.25 ± 0.030.36 ± 0.12
VLDL2 cholesterol (mmol/l)0.07 ± 0.02*0.11 ± 0.020.14 ± 0.03
VLDL2 apoB48
    Concentration (mg/l)1.12 ± 0.33*1.58 ± 0.111.56 ± 0.15
    FCR (pools/day)10.2 ± 1.9912.9 ± 1.511.3 ± 1.7
    Production rate (mg · kg−1 · day−1)
        Total0.44 ± 0.14*0.89 ± 0.080.75 ± 0.05
        Direct0.00 ± 0.01−0.03 ± 0.020.01 ± 0.02
        Via VLDL10.44 ± 0.14*0.93 ± 0.090.73 ± 0.06
VLDL2 apoB100
    Concentration (mg/dl)0.94 ± 0.31*1.68 ± 0.581.90 ± 0.47
    FCR (pools/day)15.6 ± 4.216.7 ± 2.811.7 ± 1.7
    Production rate (mg · kg−1 · day−1)
        Total5.94 ± 1.6911.2 ± 2.59.07 ± 1.52
        Direct2.54 ± 1.362.21 ± 0.652.98 ± 0.98
        Via VLDL13.40 ± 0.93*8.98 ± 2.056.09 ± 1.08
  • Data are means ± SE for the duration of the 10-h kinetic study.

  • *P < 0.05 vs. SAL.